Woman, 47, Suffered Physically and Emotionally for Years from Psoriasis. Then, One Decision Changed Everything (Exclusive)
Key Points:
- Amber Dean, who suffered from plaque psoriasis for years, experienced significant physical and emotional challenges, including pain, itching, and social embarrassment due to the chronic autoimmune condition.
- Despite trying various treatments that provided only temporary relief, Dean's symptoms worsened over time, impacting her daily life and self-confidence.
- Dean joined a clinical trial for ICOTYDE, the first FDA-approved oral medication for moderate-to-severe plaque psoriasis, developed by Johnson & Johnson.
- After treatment with ICOTYDE, Dean reports complete clearance of her skin symptoms, describing the medication as life-changing and encouraging others to consider it.
- Dean emphasizes that plaque psoriasis is a disease that does not define a person and encourages others to overcome shame and seek effective treatment options.